| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cardiff Oncology, Inc. (CRDF) has 6 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. CRDF is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 263.4K | $342.5K | - | |
| Dir | 228.1K | $296.5K | - | |
| Dir | 228.1K | $296.5K | - | |
| Dir | 209.3K | $272.1K | - | |
| Dir | 199.2K | $259.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2016 | Erlander Mark | Chief Scientific Officer | Buy | 5,000 | $2.08 | $10,375.00 | New | |
| Nov 11, 2016 | Bridger Management, LLC | Former 10% Owner | Buy | 322,472 | $3.08 | $993,213.76 | +12.2% | |
| Aug 12, 2015 | Schuh Antonius | CEO | Buy | 20,000 | $5.45 | $109,000.00 | New | |
| Aug 12, 2015 | Zaniboni Steve | CFO | Buy | 15,000 | $5.43 | $81,450.00 | +237.0% | |
| Aug 12, 2015 | Tennant Stanley | Director | Buy | 10,000 | $6.06 | $60,600.00 | +5.5% | |
| Jul 17, 2015 | Bridger Management, LLC | 10% Owner | Buy | 140,000 | $8.75 | $1,225,000.00 | +4.4% | |
| Apr 2, 2015 | Bridger Management, LLC | 10% Owner | Buy | 300,000 | $6.90 | $2,070,000.00 | +10.5% | |
| Feb 27, 2015 | Bridger Management, LLC | 10% Owner | Buy | 263,286 | $5.36 | $1,411,336.12 | +3.3% | |
| Feb 6, 2015 | Bridger Management, LLC | 10% Owner | Buy | 444,444 | $4.50 | $1,999,998.00 | +20.7% |